Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-PD-1 Antibody (5R506) is a Mouse antibody targeting PD-1. Anti-PD-1 Antibody (5R506) can be used in ELISA, WB.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 μL | $208 | 7-10 days | |
100 μL | $349 | 7-10 days |
Description | Antibody Type: Mouse Monoclonal Application: ELISA, WB Reactivity: Human |
Alias | PD-L1B7 homolog 1, PD-L1, PDL1, PDCD1LG1, PDCD1L1, CD274, B7-H1, B7H1, B7-H |
Ig Type | IgG1 |
Clone | 5R506 |
Reactivity | Human |
Verified Activity | Western Blot -Positive WB detected in: 5μg 293 whole cell lysate transfected with PD-1, 25ng recombinant protein from E.coli, 25ng recombinant protein from Mammalian cell PD-1 antibody at 1:1000 -Secondary: Goat polyclonal to mouse IgG at 1/50000 dilution -Predicted band size: 72, 36 KDa -Observed band size: 72, 36 KDa -Exposure time:5min |
Application | ELISA, WB |
Antibody Type | Monoclonal |
Host Species | Mouse |
Subcellular Localization | Cell membrane; Single-pass type I membrane protein. |
Construction | Hybridoma Monoclonal Antibody |
Purification | Protein G purified |
Appearance | Liquid |
Formulation | Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, PH 7.4. |
Purity | >95% |
Research Background | Inhibitory receptor on antigen activated T-cells that plays a critical role in induction and maintenance of immune tolerance to self. Delivers inhibitory signals upon binding to ligands CD274/PDCD1L1 and CD273/PDCD1LG2. Following T-cell receptor (TCR) engagement, PDCD1 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation. Suppresses T-cell activation through the recruitment of PTPN11/SHP-2: following ligand-binding, PDCD1 is phosphorylated within the ITSM motif, leading to the recruitment of the protein tyrosine phosphatase PTPN11/SHP-2 that mediates dephosphorylation of key TCR proximal signaling molecules, such as ZAP70, PRKCQ/PKCtheta and CD247/CD3zeta. The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival. The interaction with CD274/PDCD1L1 inhibits cytotoxic T lymphocytes (CTLs) effector function. The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy. |
Conjucates | Unconjugated |
Immunogen | Recombinant Protein: Human Programmed cell death Protein 1 Protein (21-170AA) |
Antigen Species | Human |
Gene ID | 5133 |
Uniprot ID | |
Biology Area | Immunology |
Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.